Fig. 2
From: Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009–2016)
Molecular marker analysis of drug resistance in vivax malaria in three sentinel sites in Myanmar (2014–2016). A total of 208 from three sentinel sites were included for molecular marker analysis. K10 (AAG) insert of pvcrt-O gene, and mutations of pvmdr1, pvdhps and pvdhfr were shown. Among three sites, the prevalence of all markers except F1076L of pvmdr1 were fewest in Buthidaung site